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ABSTRACT 
 
In respect to the Regional Comprehensive Economic Partnership (RCEP) talks, 
Indonesia, the ASEAN coordinator for what will be the world's largest free trade pact, 
has acclaimed the substantial progress in negotiations, which has seen leaders agree to 
complete the deal this year. On the 33rd ASEAN Summit held in 2018, President Joko 
Widodo had stressed the importance of a mandate to agree on the RCEP. However, one 
question needs to bring to light is whether Indonesia's determination has been 
supported by adequate preparedness to comply with various binding provisions, 
especially the IPR regime designed to go beyond WTO TRIPs. In an effort to answer that 
question, this article will be focused on examining the IPR regulatory framework in 
Indonesia and to what extent it is compatible with the anticipated IPR provision based 
on the leaked draft of RCEP IP Chapter. 
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Sehubungan dengan pembicaraan Kemitraan Ekonomi Komprehensif Regional (RCEP), 
Indonesia, koordinator ASEAN untuk apa yang akan menjadi pakta perdagangan 
bebas terbesar di dunia, telah mengakui kemajuan substansial dalam negosiasi, yang 
telah membuat para pemimpin sepakat untuk menyelesaikan kesepakatan tahun ini. 
Pada KTT ASEAN ke-33 yang diadakan pada tahun 2018, Presiden Joko Widodo telah 
menekankan pentingnya mandat untuk menyetujui RCEP. Namun, satu pertanyaan 
yang perlu diangkat adalah apakah tekad Indonesia telah didukung oleh kesiapan yang 
memadai untuk mematuhi berbagai ketentuan yang mengikat, terutama rezim HKI 
yang dirancang untuk melampaui TRIP WTO. Dalam upaya menjawab pertanyaan itu, 
artikel ini akan difokuskan pada pemeriksaan kerangka kerja pengaturan HKI di 
Indonesia dan sejauh mana itu sesuai dengan ketentuan HKI yang diantisipasi 
berdasarkan rancangan bagian-bagian RCEP IP yang bocor. 
 
Kata Kunci: RCEP, TRIPs Plus, Hak Kekayaan Intelektual, ASEAN, Indonesia 
 
 
Introduction 
 
The Regional Comprehensive Economic Partnership (RCEP) which was launched 
in November 2012, is currently under negotiation between ASEAN member states 
and their trading partners: Indonesia, Malaysia, Singapore, Brunei, Thailand, the 
Philippines, Myanmar, Cambodia, Vietnam, Laos, China, India, Japan, South 
Korea, Australia and New Zealand. This mega regional trade agreements which 
covers around 40% of global GDP (Ribka & Yulisman, 2016) and a two-thirds of 
world trade, is regarded as “beyond WTO trade deals”.  
 
The RCEP is not merely about greater market access and trade liberalization since 
trade liberalization is perceived as already part of the existing trade agreements 
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including NAFTA and ASEAN Economic Community (AEC). The RCEP, in this 
regard, does not only cover market access for trade agendas that have also been 
negotiating under the current Doha Round trade negotiations but it has even 
higher standard for those aspects. In addition to that, some controversial trade 
agendas, which were postponed for indefinite period in the WTO trade 
negotiations, such as government procurement, state-owned enterprises, 
intellectual property rights, e-commerce, competition policy and also investment, 
managed to find their ways to be part of the RCEP talks. Furthermore, the RCEP 
negotiations also integrate non-WTO trade agendas such as provisions regarding 
small-medium enterprises, state-owned enterprises and also Investor-State 
Dispute Settlement (ISDS) (ICTSD, 2018). 
 
This paper, however, only focuses on one of the trade aspects under negotiated 
chapters in the RCEP on Intellectual Property (IP) (hereafter the RCEP-IP) and 
its compatibility with IPR regulatory framework in Indonesia, which shows its 
intention to join the club. This report will be divided into two main parts; the first 
part is an overview and evaluation of Indonesia’s domestic situation on IPRs. This 
part focuses on the existing conditions of IPR protection in Indonesia. This 
section essentially argues that IPR protection in Indonesia is still unsatisfactory. 
The second part provides an evaluation of domestic situation on IPRs in the 
context of each TPP obligations. In doing so, this part begins with interpreting the 
RCEP-IP by comparing it with the TRIPs Agreement under the WTO. This part 
also analyses the compatibility of the Indonesian legal framework on IPR issues 
both under the RCEP-IP and the TRIPs Agreement 
 
Overview of Indonesia’s Domestic Situation on IPRs 
 
Intellectual property rights (IPR) protection was essentially an alien concept in 
Indonesia’s national laws prior to the TRIPs Agreement, due to its conflicting 
nature with Indonesia’s traditions and norms. Despite the fact that intellectual 
property (IP) legislation existed in Indonesia as early as 1844, those laws, which 
were introduced under the Dutch colonial rule, did not apply to native 
Indonesians. Under the Dutch colonial rule, the legal system for the indigenous 
Indonesians was adat (an extensive system of Indonesian customary norms), 
which did not recognize IPR protection. Under unwritten adat law, individual 
ownership in intellectual works or inventions is not recognized because 
knowledge is regarded as public property, and its main function is to serve the 
public benefit. In this regard, it is not surprising if IPR protection has no strong 
roots in Indonesian society and there was no robust Indonesian legal tradition of 
protecting IPR. A meaningful IP policy reform was then taken by the Indonesian 
government only after the Indonesian government has become a member of the 
WTO and obliged to implement the TRIPs Agreement. 
 
The lack of IPR protection acceptance in Indonesian society seems has not 
changed much even after more than a decade of IP policy reform was taken as 
part of the Indonesian obligations under the TRIPs Agreement. This is most 
evident from the fact that the number of residents’ patent application in 
Indonesia is considerably low as compared to non-residents’ patent application. 
As can be seen from the WIPO statistical database from 2008 to 2017, more than 
75% out of a total of 9,352 of patent applications in Indonesia is by non-resident. 
In addition, as compared to the other RCEP countries, Indonesia’s performance 
based on Property Rights Index in 2018 is also relatively poor. Indonesia with an 
average score of 5.3 is still behind New Zealand (8.6), Singapore (8.4), Australia 
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(8.3), Japan (8.2), Malaysia (6.49), South Korea (6,47), China (5.9), India (5.6), 
and mere slightly performs better than Thailand (5.3), Philipines (5.2), and 
Vietnam (5.07). Furthermore, Indonesia’s relatively poor performance based on 
Property Rights Index has also supported by the fact that Indonesia along with 
India and China have always been on the USTR Priority Watch List in between 
2010 and 2019. Based on the USTR Special 301 Report 2019, one of the main 
reasons why Indonesia has remained in the USTR Priority Watch List is that 
widespread piracy and counterfeiting dangerous products. Indonesia also still 
suffers from lack of effective system for protecting against the unfair commercial 
use for pharmaceutical and agricultural chemical products. In addition, there are 
some concerns regarding market access barriers related to the importation of 
motion pictures and import medicines particularly on technology transfer 
requirements (USTR, 2019). 
 
Based on previous explanation, it is clear that IPR protection in Indonesia still 
needs to be improved and has become the concern of the US government as one 
of Indonesia’s leading trading partners. This existing condition also shows that if 
Indonesia intends to join the TPP, there are many aspects on IPR protection that 
need to be enhanced. 
 
Indonesia’s IPR national laws and RCEP-IP Obligations 
 
This section evaluates Indonesia’s domestic situation on IPRs in the context of 
each RCEP obligations. The first part of this section explains the obligations 
under the RCEP by comparing the RCEP-IP Chapter with the TRIPs Agreement 
under the WTO. This part also analyses the compatibility of the Indonesian legal 
framework on IPR issues both under the RCEP-IP Chapter and the TRIPs 
Agreement. 
 
1. Understanding the RCEP-IP protection 
 
The RCEP-IP Chapter rules the protection for patents, trademarks, copyrights, 
industrial designs, geographical indications, trade secrets, other forms of 
intellectual property, and enforcement of intellectual property rights. The RCEP-
IP protection consists of 11 Sections, 83 Articles, and 6 Annexes. It is regarded as 
“beyond the TRIPs Agreement” or “TRIPs Plus”. It does not only adopt the basic 
principles of the TRIPs Agreement on National Treatment (Article 18.8) but also 
provides more tight stringent protection for IPR. Interestingly, however, the 
RCEP-IP does not include the other non-discrimination principle under the 
TRIPs, i.e. Most Favoured Nations (MFN). In addition, the RCEP also 
incorporates several new aspects that are not part of the TRIPs Agreement. 
 
There are some additional clauses related to IPR protection that are not available 
under the TRIPs Agreement but they are included in the RCEP. The RCEP has 
specific clause on transparency, which requires each Party to make available its 
laws, regulations, procedures and administrative rulings of general application 
concerning the protection and enforcement of intellectual property rights. More 
specifically, the RCEP also requires its Parties to make available on the Internet, 
any information concerning applications for, registered and granted trademarks, 
geographical indications, designs, patents and plant variety rights (Article 18.9). 
These requirements on the availability of the information in the Internet are not 
part of the TRIPS Agreement. 
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The RCEP includes a clause on the cooperation in the area of traditional 
knowledge (Article 18.16). While the TRIPs Agreement does not have specific 
clause on traditional knowledge, the RCEP “…recognize(s) the relevance of 
intellectual property systems and traditional knowledge associated with genetic 
resources to each other, when that traditional knowledge is related to those 
intellectual property systems” (Article 18.16.1). In this regard, the RCEP also 
emphasizes the importance of documented information and the use of databases 
or digital libraries, which related to traditional knowledge associated with genetic 
resources. 
 
As for trademarks protection, the RCEP has higher protection for trademarks as 
compared to the TRIPs Agreement. The RCEP protects sound and scent marks 
(Article 18.19). The RCEP requires its Parties to provide terms of protection for 
trademarks no less than 10 years while the TRIPs Agreement only requires the 
protection for trademarks no less than 7 years. The RCEP-IP also introduces a 
new mechanism called electronic trademark system, as system for the electronic 
application for and maintenance of trademarks (Article 18.24). In addition, the 
RCEP is also beyond the TRIPs Agreement in regard to the well-known 
trademarks, as it specifies the exclusive rights of well-known trademark owners 
and the obligations of each party to provide appropriate measures to protect them 
(Article 18.22). 
 
The RCEP specifically addresses the inappropriate use of country names (Section 
D). Article 18.29 states that “each Party shall provide the legal means for 
interested persons to prevent commercial use of the country name of a Party in 
relation to a good in a manner that misleads consumers as to the origin of that 
good”. The TRIPS Agreement does not have a specific clause on the prevention of 
commercial use of the country name. 
 
Under the RCEP, there are several clauses to ensure prevention of the excessive 
use of geographical indications (Article 18.32) especially on Grounds of 
Opposition and Cancellation. Under these provisions, the RCEP provides 
safeguard in order to ensure that the protection of Geographical Indication will 
not cause confusion with pre-existing trademark. Furthermore, the GI is 
considered as not legitimate if it uses common name for relevant good. These 
provisions clearly benefit countries that usually use common names to export 
their products and also for countries that do not protect the generic terms of the 
product like in the US. In addition, Article 18.35 of RCEP also rules the date of 
protection of a GI, which is no earlier than the filing date or registration date. 
These specific provisions on GI are beyond the TRIPs Agreement. 
 
Regarding patents, the RCEP adds some clauses and more detailed explanations, 
which are not available under the TRIPs Agreement. Article 18.37 for example 
provides a detailed explanation on defining inventions that have to meet one of 
the following conditions: new uses of a known product, new methods of using a 
known product, or new process of using a known product. The RCEP also 
declares first-to-file principle (Article 18.42), while under the TRIPs Agreement 
the Members are able to choose their own patent filing principles, first-to-file or 
first-to-invent. In addition, the RCEP-IP also has a provision on patent term 
adjustment in order to compensate unreasonable granting authority delays 
(Article 18.46). Such a provision is unavailable under the TRIPs Agreement. 
The RCEP-IP provides a broad definition on new pharmaceutical product as does 
not contain a chemical entity that has been previously approved (18.52). This 
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obviously will benefit pharmaceutical companies. Interestingly, some provisions 
under the TRIPs Agreement that are designed to protect the needs of developing 
countries are not specifically addressed, such as parallel importation and 
compulsory licensing. Under the RCEP, no specific clause on compulsory 
licensing other than permitted under the TRIPs Agreement as reflected under 
Article 18.6, which recognises the adoption of Doha Declaration. 
 
The RCEP also includes new clauses on the protection of undisclosed test data 
submitted for marketing approvals. In the case of agricultural chemicals it 
provides protection at least 10 years and 5 to 8 years in the case of 
pharmaceuticals (Article 18.50). The TRIPs Agreement does not have such a 
requirement. Furthermore, the RCEP specifically addresses the protections for 
new pharmaceutical products that are or contain a biologic and provides 
minimum terms of protection of 8 years (Article 18.51). This has made the RCEP 
as the first trade agreement to include such a provision. 
 
As regard to industrial design, the RCEP has a specific clause on improving 
industrial design system particularly to facilitate the process of the cross-border 
acquisition of rights (Article 18.56). The TRIPs Agreement does not specify the 
cross-border acquisition of rights in the Parties’ respective industrial design 
systems. 
 
In copyrights, the RCEP extends the duration of copyrights protection. Under the 
TRIPs Agreement the duration of copyrights protection is the life of the author 
and 50 years after the author’s death. Under the RCEP, the protection is extended 
to the minimum of 70 years after the author’s death (Article 18.63). In addition, 
the RCEP also incorporates new provisions on Technological Protection Measures 
(TPMs) Article 18.68; Rights Management Information (RMI) Article 18.69; and 
Collective Management (Article 18.70). Under the Collective Management clause, 
the RCEP allows the recognition of the important role of collective management 
societies for copyright and related rights in collecting and distributing royalties. 
Based on previous explanation, it is clear that the RCEP-IP can be regarded as 
beyond the TRIPs Agreement or “TRIPs Plus”. According to Braga (2016), the 
RCEP-IP provides higher standards for IPR protection in line with the US law 
and reflects the existing FTAs that signed and negotiated by the US. 
 
2. Compatibility of the Indonesian legal framework on IPR 
 
This part discusses the compatibility of the Indonesian legal framework on IPR 
issues both under the RCEP-IP and the TRIPs Agreement. As explained 
previously, the RCEP has higher protection for trademarks as compared to the 
TRIPs Agreement. While Indonesia’s trademark legislation can be categorized as 
TRIPs Plus, Indonesia’s trademarks legislation in general is also compatible with 
the RCEP-IP. As will be discussed below, there are some aspects, however, that 
still need to be adjusted in order for Indonesia to be fully RCEP-IP compliance. 
In terms of the scope, the RCEP protects sound and scent marks (Article 18.19). 
The Indonesia’s existing law on trademarks does not recognize non-traditional 
visible and non-visible marks such as sound and scent marks. Indonesia needs to 
amend these aspects. Nevertheless, whether the protection of these types of 
marks is compatible or not with the current development in Indonesia or this will 
only serve the interest of foreign trademarks owners is still questionable. 
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The RCEP is also beyond the TRIPs Agreement in regard to the well-known 
trademarks, as it specifies the exclusive rights of well-known trademark owners 
and the obligations of each party to provide appropriate measures to protect them 
(Article 18.22). These include an obligation to the Parties to refuse the application 
or cancel the registration and prohibit the use of a trademark that is identical to a 
well-known trademark and also to prohibit the Parties to require a registration 
for a well-known trademark that has been registered in the Party or in another 
jurisdiction. The existing Indonesia’s trademark law has met this obligation 
including to prevent the registration of identical or similar trademark to a well-
known trademark. 
 
The RCEP-IP also introduces a new mechanism called electronic trademark 
system, as system for the electronic application for and maintenance of 
trademarks (Article 18.24). To date, Indonesia does not have online trademark 
registration, as a consequence infrastructure for this purpose needs to be 
established. In the long run it will be beneficial for trademark owners in 
Indonesia since it is more efficient and cost-effective system. In the short term, 
however, it requires massive investment to establish sufficient infrastructure 
nation wide. 
 
The RCEP requires its Parties to provide terms of protection for trademarks no 
less than 10 years while the TRIPs Agreement only requires the protection for 
trademarks no less than 7 years. There is no problem with this requirement since 
the existing Indonesia’s national law on trademarks has met this obligation. This 
can be understood, as explained in the previous part, considering that trademark, 
as one of the forms of intellectual property rights historically is more acceptable 
in Indonesian society due to its nature to protect the need of society to have a 
better quality of the products. 
 
To conclude, in terms of trademark protection, the Indonesia’s domestic situation 
and the Indonesia’s current law in general can be regarded as RCEP-IP 
compliance. Nevertheless, there are two main aspects that still need to be 
adjusted, i.e. expanding the scope of trademark to include non-traditional visible 
and also non-visible marks as protected trademarks as well as establishing 
electronic trademark registration system. Despite the fact, only these two aspects 
that have not met the minimum requirement of the RCEP-IP, adjusting the 
Indonesian law to accommodate these two aspects can be problematic 
considering the current Indonesia’s domestic situation. 
 
As discussed in previous part, under the RCEP, there are several clauses to ensure 
prevention of the excessive use of geographical indications (Article 18.32) 
especially on Grounds of Opposition and Cancellation. Under these provisions, 
the RCEP provides safeguard in order to ensure that the protection of 
Geographical Indication will not cause confusion with pre-existing trademark. 
Furthermore, the GI is considered as not legitimate if it uses common name for 
relevant good. The RCEP-IP also requires the Parties to ensure transparency, 
publicly available information, and mechanism for cancellation (Article 18.31 & 
18.32). In this regard, Indonesia needs to improve its administration procedure 
and cancellation and makes these publicly available as required by the RCEP-IP. 
Improving its administration procedure for GI protection will be beneficial for 
Indonesia and this may also encourage the utilization of GI protection to protect 
Indonesia’s rich cultural heritage. 
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Previous section has shown that the RCEP-IP is beyond the TRIPs Agreement for 
patents protection. The RCEP adds some clauses and more detailed explanations, 
which are not available under the TRIPs Agreement (see table 8). Article 18.37 for 
example provides a detailed explanation on defining inventions that have to meet 
one of the following conditions: new uses of a known product, new methods of 
using a known product, or new process of using a known product. Under the 
TRIPs Agreement, a new invention can be granted a patent if it can be proven as 
new and involve an inventive step and capable of industrial application. The 
Indonesia’s patent law adopts the definition of invention of the TRIPs Agreement. 
Furthermore, not all patents can be granted under the Indonesian patent law. The 
obligation under Article 18.37.2 is in conflict with the interest of the Indonesian 
government especially to provide more affordable medicines for its people. The 
Indonesian government does not recognize the new definition of inventions 
under the RCEP-IP. Recognizing these aspects to be patentable will expand the 
opportunity of pharmaceutical companies to protect their privileges. 
 
The RCEP also declares first-to-file principle (Article 18.42), while under the 
TRIPs Agreement the Members are able to choose their own patent filing 
principles, first-to-file or first-to-invent. Since Indonesia adopts first-to-file 
principle, this is in line with the RCEP’s requirement. 
 
In addition, the RCEP-IP also has a provision on patent term adjustment in order 
to compensate unreasonable granting authority delays (Article 18.46). Such a 
provision is unavailable under the TRIPs Agreement. Indonesia’s patent 
legislation does not have procedure to expedite the examination of patent 
applications. Furthermore, there is no clause regarding compensation for 
unreasonable granting authority delays. The procedure to expedite the 
examination process can be beneficial since it can encourage more patent 
applications. However, on the other hand the compensation mechanism for 
authority delays may also be regarded as extending the protection of patented 
products, which in turn benefiting the existing patents owners. 
 
The RCEP also includes new clauses on the protection of undisclosed test data 
submitted for marketing approvals. In the case of agricultural chemicals it 
provides protection at least 10 years and 5 to 8 years in the case of 
pharmaceuticals (Article 18.50). The TRIPs Agreement does not have such a 
requirement. This will harm society’s interests since even after the end of patent 
protection, other companies cannot use “the undisclosed test or other data” that 
suppose to be freely available and can be used to produce generic medicine. This 
is because under the RCEP-IP, it has to wait for at least 5 (or 8) years after the 
end of its patents protection for the undisclosed test or other data to be freely 
used. This can also be regarded as a way to lengthen the monopoly of 
pharmaceutical industries. 
 
Furthermore, the RCEP specifically addresses the protections for new 
pharmaceutical products that are or contain a biologic and provides minimum 
terms of protection of 8 years (Article 18.51). This has made the RCEP as the first 
trade agreement to include such a provision. In this context, Indonesia’s patent 
law needs to be adjusted to accommodate this new clause. An important issue to 
discuss further is that how granting protection for new pharmaceutical products 
that contain biological element will be beneficial for Indonesian society. How far 
the capacity of domestic pharmaceutical industries is able to utilize this and to 
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what extent this clause will not only provide another privilege for foreign 
pharmaceutical industries. 
 
The RCEP provides a broad definition on new pharmaceutical product as does 
not contain a chemical entity that has been previously approved (18.52). This 
obviously will benefit pharmaceutical companies. Indonesia’s legal law on patent 
acknowledges the novelty of an invention to be patented. The clause under the 
RCEP-IP requires the amendment of definition of new pharmaceutical product 
and expanding the definition, which does not necessarily reflect any novelty. This 
will provide a greater chance for pharmaceutical industries to also extend their 
monopoly. 
 
As regard to industrial design, the RCEP has a specific clause on improving 
industrial design system particularly on facilitating the process of the cross-
border acquisition of rights (Article 18.56). The TRIPs Agreement does not 
specify the cross-border acquisition of rights in the Parties’ respective industrial 
design systems. Indonesia’s industrial design law does not have specific 
provisions on this issue. In this regard, the Indonesian government needs to 
improve the infrastructure and enhance its human resource to facilitate the 
process of the cross-border acquisition of rights. 
 
In copyrights, the RCEP extends the duration of copyrights protection. Under the 
TRIPs Agreement the duration of copyrights protection is the life of the author 
and 50 years after the author’s death. Under the RCEP, the protection is extended 
to the minimum of 70 years after the author’s death (Article 18.63). In addition, 
the RCEP also incorporates new provisions on Technological Protection Measures 
(TPMs) Article 18.68; Rights Management Information (RMI) Article 18.69; and 
Collective Management (Article 18.70). Under the Collective Management clause, 
the RCEP allows the recognition of the important role of collective management 
societies for copyright and related rights in collecting and distributing royalties. 
For all those aspects, Indonesia’s current copyright law has already complied with 
the RCEP-IP. 
 
As regard to trade secret protection, the Indonesian law to some extent has met 
the minimum requirements under the RCEP’s IP (see table 11). Indonesian 
current law on trade secret provides specific criminal provisions to prevent 
misappropriation of trade secrets. However, the Indonesian national legislation 
does not have specific clause on preventing misappropriation of trade secrets 
conducted by state-owned enterprises (SOEs). 
 
Based on previous discussion, it can be concluded that there are three categories 
of Indonesian laws compatibility with the RCEP’s IP. First category is fully 
comply with the RCEP’s IP, i.e. copyrights; the second category is RCEP’s minus 
with only minor revision and the revision will be beneficial for Indonesia; the 
third category is RCEP’s minus with major revisions and whether the adjustment 
taken will be beneficial or not for Indonesia is still questionable so requires more 
comprehensive assessment, which beyond the main objective of this report. 
 
In addition to ensure the compatibility of national laws on IPRs, the TPP 
members are also required to ratify some other international agreements on IPR 
other than the TRIPs Agreement. These include Patent Cooperation Treaty, Paris 
Convention, Berne Convention, Madrid Protocol, Budapest Treaty, Singapore 
Treaty, UPOV, WIPO Copyright Treaty, WIPO Performance and Phonogram 
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Treaty. Among these agreements, Indonesia only ratifies some of them: Paris 
Convention, WIPO Copyright Treaty and WIPO Performance and Phonogram 
Treaty and accedes to Patent Cooperation Treaty and Berne Convention. There 
are four main international IP agreements that have not been ratified or accessed 
by the Indonesian government, i.e. Madrid Madrid, Budapest Treaty, Singapore 
Treaty, and UPOV. This means, if Indonesia intends to join the TPP, Indonesia 
will be required to ratify or accede to the rest of international IP agreements. 
 
Madrid Protocol governs the international trademark system. It provides a one 
stop mechanism for registering and managing marks worldwide (WIPO, n.d). It 
means that any trademark once it is registered at national or regional IP office 
can also be submitted for international application through the same IP office 
which will certify and forward it to WIPO. After formal examination and 
approved by WIPO, the trademark will be recorded in the international register 
and published in the WIPO Gaxette of International Marks. However, even 
though the trademark has been approved by the WIPO, the national or regional 
IP offices also still need to conduct substanive examination and made final 
decisions regarding the protection of the trademark according to their legislation. 
In this regard, this system will simply the mechanism for international 
registration yet the national government still has the right to acknowlegde or not 
to acknowledge the registered trademark. This system will be benefiting domestic 
trademark owners to be recognised and gained international protection (see 
diagram 1). 
 
Diagram 1. The Madrid Protocol 
 
Source: WIPO (n.d). 
 
The Budapest Treaty of 1980 rules international patents process related to 
inventions involving microorganisms. Under the Budapest system, all states party 
to the treaty are obliged to recognise microorganisms deposited as a part of the 
patent disclosure procedure with an international Depositary Authority (IDA). In 
this regard, there is no requirement for the patent applicants to submit 
microorganisms to national authority (WIPO, n.d). This system offers an efficient 
and cost-effective means for the applicants in meeting the disclosure 
requirements for patenting microorganisms. However, on the other hand, 
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national government will not have the authority to examine the inventions 
involving microorganisms. 
 
The Singapore Treaty on the Law of Trademarks was adopted in 2006. Its main 
objective is to create a modern and dynamic international framework for the 
harmonisation of administrative trademark registration procedures especially 
expanding the scope in order to accommodate more recent developments in the 
field of communication technologies (WIPO, n.d). The Singapore Treaty in this 
regard is the first international instrument on trademark, which includes non-
traditional visible marks, such as holograms, three-dimensional marks, colour, 
position and movement marks, as well as, non-visible marks such as sound, 
olfactory or taste and feel marks (WIPO, n.d). The current Indonesia’s national 
law on trademark does not recognise non-traditional visible marks and non-
visible marks. There should be a comprehensive assessment to evaluate as to 
whether expanding the scope of trademarks will be beneficial for Indonesian 
economic actors. Otherwise, expanding the scope of trademarks will provide 
protection and only be benefiting foreign trademarks owners. 
 
The International Union for the Protection of New Varieties of Plants (UPOV) 
was initially adopted in Paris in 1961 and then revised several times in 1972, 1978 
and 1991. The main purpose of this convention is to provide and promote an 
effective system of plant variety protection with the aim of encouraging the 
development of new varieties plants. Furthermore, the UPOV convention also 
encourages plant breeding by granting breeders of new plant varieties as an 
intellectual property right (UPOV, n.d). New varieties plants issue is governed 
under the Indonesia’s legal system UU No. 29/2000 on Protection of Plant 
Varieties. The main purpose of this law is to protect Indonesia’s interest as 
agricultural country and to ensure the availability of plant varieties for 
agricultural development. Interestingly, the legislation is not designed to grant 
patent protection for the new plant varieties. Ratifying the UPOV convention will 
change the nature of the protection in Indonesia as the Convention grants 
breeders of new plant varieties an intellectual property right. 
 
Conclusion 
 
Based on previous explanation, it can be concluded that The RCEP-IP Chapter 
can be regarded as beyond the TRIPs Agreement or “TRIPs Plus”. The RCEP-IP 
Chapter provides higher standards for IPRs protection in line with the US law 
and reflects the existing FTAs that signed and negotiated by the US (Braga, 2016). 
Despite the fact that the Indonesia’s existing IP legislation is TRIPs compliance, 
some aspects under the Indonesia’s existing legal framework, however, are 
incompatible with the RCEP-IP. In this regard, if Indonesia intends to join the 
RCEP, it is crucial to ensure Indonesian legal framework compatibilities with the 
RCEP and also to ratify other international agreements on IP that have not been 
ratified by the Indonesian government. This may not be easy since the process for 
amending national laws and also ratifying international agreements under the 
current legislation process cannot be done in short period of time. 
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